About Fusion Antibodies

What does Fusion Antibodies do?

Fusion Antibodies is a provider of humanized monoclonal antibody production and antibody engineering services, including mammalian display for high-volume screening, antibody humanization (CDRx), affinity maturation (RAMP), OptiMAL mammalian antibody library for discovery and preclinical optimization, integrated antibody discovery strategies, and protein engineering.

Who are Fusion Antibodies's competitors?

Fusion Antibodies's competitors and similar companies include Ergomed, SSI Strategy, Amatsigroup, Halloran Consulting Group, and Alphora Research.

Where is Fusion Antibodies headquartered?

Fusion Antibodies is headquartered in United Kingdom.

How many employees does Fusion Antibodies have?

Fusion Antibodies has 1,000 employees 🔒.

When was Fusion Antibodies founded?

Fusion Antibodies was founded in 2010 🔒.

What sector and industry vertical is Fusion Antibodies in?

Fusion Antibodies is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Fusion Antibodies

Who are the top strategic acquirers in Fusion Antibodies's sector and industry

Top strategic M&A buyers and acquirers in Fusion Antibodies's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Fusion Antibodies?

Top strategic M&A buyers groups and sectors for Fusion Antibodies include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Fusion Antibodies's sector and industry vertical

Which are the top PE firms investing in Fusion Antibodies's sector and industry vertical?

Top PE firms investing in Fusion Antibodies's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Fusion Antibodies's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Fusion Antibodies's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Fusion Antibodies's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Fusion Antibodies include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Fusion Antibodies's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Fusion Antibodies?

The key public trading comparables and valuation benchmarks for Fusion Antibodies include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Fusion Antibodies for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Fusion Antibodies with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Fusion Antibodies's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Fusion Antibodies with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Fusion Antibodies's' sector and industry vertical?

Access recent funding rounds and capital raises in Fusion Antibodies's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.